Tuesday, February 9, 2010

Alzhermer drug?

The market will rebound at the opening. I do not expect it to be strong. I may sell 200 HSE if it reaches 27.3.

Pay attention to MDVN. Its Alzheimer's drug is in phase 3 trial and could become the most important drug in 10 years. I will buy 100 @36. Be aware that it is a high risk investment.

No comments:

Post a Comment